Global Uranium stocks tested fresh 2025 highs last week, but our attempt to buy Paladin (PDN) fell short. However, after a 1% dip by the URNM ETF in the US on Friday night, we’re keen to garner exposure to the uranium sector into likely early weakness this week.
- We believe the risk/reward towards the ASX-traded URNM ETF is attractive into a dip.